CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $434K invested in Can-Fite BioPharma in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$189K
2
+$108K
3
+$27K
4
Morgan Stanley
Morgan Stanley
New York
+$22.3K

Top Sellers

1
-$25K
2
-$24K
3
-$21K
4
GWM
Geneos Wealth Management
Colorado
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$212K
2
$132K
3
$31K
4
$31K
5
$27K
6
$949
7
–
8
–
9
–
10
–